This article first appeared on GuruFocus .
Release Date: August 14, 2026
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
Positive Points
-
Praj Industries Ltd ( BOM:522205 ) received an order for India's first commercial-scale demo plant for Bio-IBA (isobutanol), with a potential 2% blending mandate creating a project opportunity of over INR 3,000 crore.
-
The company secured a significant global supply agreement for hyperscale data center infrastructure, guaranteeing a minimum business volume of about US$50 million over the next 2.5 years, marking strategic diversification.
-
Praj Industries Ltd ( BOM:522205 ) received an order for a large greenfield corn-to-ethanol plant in Brazil, establishing a marquee reference in the region.
-
The Union Cabinet approved the Govardhan scheme with a total outlay of over INR 23,000 crores, which is expected to be an inflection point for the CBG sector and create significant opportunities for the company.
-
The company received an order for detailed engineering for an ethanol-to-SAF plant from an international customer, and ICAO officially approved the sugarcane-to-jet pathway, positioning Praj as a technology partner.
-
Praj Industries Ltd ( BOM:522205 ) secured its first combined contract for ultra-pure water and ZLD solutions for a semiconductor company in India, expanding into new emerging industry segments.
Negative Points
-
The domestic first-generation ethanol business continues to experience a slowdown in greenfield projects, with inquiries only coming from ethanol deficit areas like Tamil Nadu and Assam.
-
Funding-related issues persist in project backlog execution, leading to extended project execution cycles and impacting backlog conversion to revenues.
-
The supply-demand imbalance in the ethanol market has negatively impacted the conversion of project backlog into revenues.
-
The company's margins were subdued in Q1 FY27 due to lower volumes and an unfavorable mix, with export revenues declining year-over-year.
-
Rising material costs, particularly on the steel side, are creating pressure on margins, although the company is taking measures to counter this.
-
The GenX business is still not at breakeven, and the company expects to achieve EBITDA breakeven only by the end of the current fiscal year.
Q & A Highlights
-
Warning! GuruFocus has detected 6 Warning Signs with BOM:522205.
-
Is BOM:522205 fairly valued? Test your thesis with our free DCF calculator.
Q: What does the US$50 million global supply agreement for hyperscale data centers mean for the trajectory of Praj Genex, and how large can this business become over the medium term? A: Ashish Gaikwad, Managing Director: This agreement marks a strategic diversification into a high-growth global engineering market outside of Praj's core bioenergy business, leveraging our mega manufacturing capacity at Mangalore. We are pivoting to this new area and will deliver our first project over Q2-Q4 of this year. As we gain more knowledge from the segment, we expect this to become a sustainable vertical within Praj Genex that will sustain orders and revenue over time.
Q: Can you explain the execution challenges in the Bioenergy segment this quarter, and how are funding issues and material costs impacting performance? A: Ashish Gaikwad, Managing Director: The domestic first-generation ethanol plants are experiencing extended execution cycles due to funding issues for end customers and the supply-demand imbalance in the ethanol market. This has a rub-off effect on collections. Sachin Raule, Joint MD & CFO: There is an upward trend in material costs due to the geopolitical scenario. We are countering this through contractual arrangements and advanced procurement, but it remains a pressure point.
Q: What is the status of the Bio-IBA (isobutanol) project, and what is the potential market opportunity? A: Ashish Gaikwad, Managing Director: We have received an order for India's first commercial-scale demo plant for Bio-IBA, with construction expected to be completed by December 2026. Government agencies are testing Bio-IBA blended into diesel. A 2% blending mandate for bio-IBA in diesel has the potential to create over INR 3,000 crore in project opportunities. Praj is ready with the technology if mandates come.
Q: What is the scope and value of the greenfield corn-to-ethanol plant order in Brazil? A: Ashish Gaikwad, Managing Director: We received an order for a greenfield grain-to-ethanol plant in Brazil, which is a corn-to-ethanol project of approximately 800 KLPD capacity. This is a fairly large capacity and a marquee reference for Praj in the region. Sachin Raule, Joint MD & CFO: The scope can range from 50% to 60% of the project value, depending on what we undertake, including process technology and critical equipment.
Q: How will the government's Govardhan scheme (National Circular Bioenergy Scheme) impact the CBG business, and what is Praj's readiness? A: Ashish Gaikwad, Managing Director: The scheme, with a total outlay of over INR 23,000 crores, transforms CBG into a bankable infrastructure asset through assured demand, stable pricing, and capital assistance. This is expected to be an inflection point for investments. Praj has proven technology on multiple feedstocks like press mud, rice straw, and napier grass, and we are ready to leverage this opportunity. We are also pursuing joint ventures, including with oil marketing companies, to accelerate market capture.
Q: What is the reason for the decline in export revenues this quarter, and when will the recent international orders convert to revenue? A: Sachin Raule, Joint MD & CFO: The decline is due to the entry points of export orders and their execution cycles. We received a large chunk of export orders this quarter, but execution will start from the third quarter once engineering is done. Ashish Gaikwad, Managing Director: International orders are about 40-43% of the mix this quarter, and this share will start reflecting in revenue in the coming quarters, improving from the current 25-30% share.
Q: What is the timeline for Praj Genex to achieve breakeven, and how much of the required top-line can be achieved by the existing backlog? A: Sachin Raule, Joint MD & CFO: We are working towards an EBITDA breakeven for Genex by the end of this financial year. The data center orders have shorter delivery cycles, so orders received in Q1 may be delivered before the end of the fiscal year. The buildup happening right now is very impressive, and we believe the results will show in the latter part of this financial year.
Q: What is the typical CapEx for a 100 KLPD isobutanol plant, and what is Praj's scope in such projects? A: Sachin Raule, Joint MD & CFO: A 100 KLPD ethanol plant can cost between INR 100-120 crores, depending on feedstock and final product. Praj's scope generally ranges from 50% to 60%, covering the process and technology parts, including critical equipment. Depending on geography and necessity, we can also undertake installation and construction activities.
Q: How is Praj addressing the margin pressure, and what is the strategy for structural margin improvement? A: Ashish Gaikwad, Managing Director: We are working on improving the mix across several dimensions: domestic versus international orders, projects versus services, and first-generation ethanol versus new biofuels like isobutanol and CBG. Services margins are definitely better than product margins, and as we increase the share of services by leveraging our installed base, we hope to improve overall margins. Sachin Raule, Joint MD & CFO: We are investing in R&D and Genex, which takes out a chunk of margin currently, but these investments are meant to expand our product portfolio and technology basket for future growth.
Q: What is the status of the CBG joint venture with BPCL, and how is Praj approaching the municipal solid waste (MSW) segment? A: Ashish Gaikwad, Managing Director: We continue to pursue the JV discussions, and with the Govardhan scheme coming into play, we will likely be able to speed up these discussions. On MSW, the crux of the challenge is feedstock segregation. We are looking at ways to solve these challenges but are not aggressively pursuing this segment until we have good solutions. We are not ignoring it completely, but it is not a current priority.
For the complete transcript of the earnings call, please refer to the full earnings call transcript .
